Our collaborator at Charles River, Julia Schüler, PhD DVM wrote a blog post titled Finally, Reliable Drug Screening Platforms for Lung Cancer Biomarkers, discussing the impact of 3D Tumor Models in screening patient-derived NSCLC tumors.
Our collaborator at Charles River, Julia Schüler, PhD DVM wrote a blog post titled Finally, Reliable Drug Screening Platforms for Lung Cancer Biomarkers, discussing the impact of 3D Tumor Models in screening patient-derived NSCLC tumors.